Federal Register Notice: FDA will hold a public hearing 4/23-24 to obtain input on the agency’s direction in modernizing the regulations, policies, and practices that apply to the conduct of clinical trials of FDA-regulated products. The agency is involved in an effort to modernize the regulatory framework that governs clinical trials and approaches to good clinical practice. The hearing will be held from 8:30 a.m. to 4:30 p.m. at FDA’s White Oak Campus, 10903 New Hampshire Ave., Bldg. 31, Rm. 1503, Silver Spring, MD. A live Webcast of this public hearing can be viewed at http://www.fda.gov/Drugs/NewsEvents/ucm284118.htm. A video record of the public hearing will be available at the same Web address for one year. Contact Jennifer Hymiller, (301) 796-2147. To view this notice, click here.